Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.46M | 12.19M | 10.29M | 10.34M | 11.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.87M | 52.62M | 45.51M | 44.06M | 48.77M |
| Operating Income | -37.87M | -52.62M | -45.51M | -44.06M | -48.77M |
| Income Before Tax | -47.21M | -58.83M | -42.15M | -93.80M | -49.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.21M | -58.83M | -42.15M | -93.80M | -49.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.21M | -58.83M | -42.15M | -93.80M | -49.39M |
| EBIT | -37.87M | -52.62M | -45.51M | -44.06M | -48.77M |
| EBITDA | -35.48M | -49.57M | -42.32M | -41.21M | -45.12M |
| EPS Basic | -0.17 | -0.21 | -0.16 | -0.39 | -0.21 |
| Normalized Basic EPS | -0.08 | -0.11 | -0.11 | -0.11 | -0.13 |
| EPS Diluted | -0.17 | -0.21 | -0.16 | -0.39 | -0.21 |
| Normalized Diluted EPS | -0.08 | -0.11 | -0.11 | -0.11 | -0.13 |
| Average Basic Shares Outstanding | 276.86M | 275.88M | 260.49M | 238.41M | 237.58M |
| Average Diluted Shares Outstanding | 276.86M | 275.88M | 260.49M | 238.41M | 237.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |